Background The concept of ischaemia for therapeutic guidance and risk stratification in coronary artery disease has been challenged in recent years. In particular, there is limited understanding of ...

Treatment with digitoxin cut the absolute risk of all-cause mortality and hospitalization for worsening HF by 4.6% compared with placebo over a median follow-up of 36 months (HR 0.82; 95% CI 0.69-0.98 ...

The REBOOT trial, coordinated by the CNIC, shows that treatment with beta-blockers provides no benefit to patients who experience an uncomplicated heart attack that leaves the contractile function of ...

Madrid, August 30, 2025. An international clinical trial coordinated by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in ...

Background Stroke volume is an established echocardiographic marker but has not been widely studied in patients with ...

Shares of Tectonic Therapeutic (TECX) soared about 6% in Wednesday’s pre-market after Oppenheimer initiated coverage of the ...

There is decreased risk for clinical events among high-risk patients with CVD who have higher educational attainment level.

There is higher risk of in-hospital mortality in women, compared with men, with cardiogenic shock who receive extracorporeal cardiopulmonary resuscitation.

Caballero was banged one pitch into his fourth inning at-bat for disputing plate umpire Ramon De Jesus calling a swinging ...

Liverpool Face Growing Battle for GuehiTransfer collapse creates wider openingLiverpool thought they had found their ...

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across ...

CAMZYOS reduces left ventricular ejection fraction (LVEF) and can cause heart failure due to ... patients in the placebo group experienced reversible reductions in LVEF 50% (median 48%: range 35-49%) ...